Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Misonix signs new sales agency agreement with AOS
The agreement provides Advanced Oncology Systems (AOS) with the rights to sell in most eastern European countries, with a primary focus in Hungary, Poland, Romania, Bulgaria, the Russian
The agreement provides Advanced Oncology Systems (AOS) with the rights to sell in most eastern European countries, with a primary focus in Hungary, Poland, Romania, Bulgaria, the Russian
Enobia is investigating enzyme replacement therapy (ERT) with ENB-0040 for the treatment of this rare and often crippling genetic bone disorder for which there is no approved treatment.
In this newly created role, Mr White will be responsible for the strategic direction and overall management of the company’s commercial operations as it advances a broad portfolio
The three-year agreement is available to members of the Premier healthcare alliance. Nihon Kohden said that its patient monitoring solutions utilize miniaturization technology and high speed processing to
Dr Martin will manage Dynavax’s clinical affairs, including the development of Dynavax’s three current clinical-stage product candidates and three preclinical candidates, which are expected to enter clinical development
The company has recorded total revenues of $15.32 million for the fourth quarter of 2008, an increase of 53%, compared to $10.02 million for the same period of
Net revenue increased 1.5% to $92.2 million for the fourth quarter of 2008, compared with $90.8 million for the prior-year period. For the full year 2008, net revenue
This one-year Phase I Small Business Innovative Research (SBIR) grant will fund the development of novel HIV entry drugs that overcome limitations of current therapies, the company said.
According to Seegene, Seeplex MTB ACE provides simple and fast detection in a single multiplex PCR that uses multiple genetic targets – IS6110 and MPB64. The Seeplex MTB
AppliChem and Akron Biotech are merging forces for the manufacturing and distribution of both companies’ products. Effective March 2, 2009, Akron Biotech has taken over AppliChem’s operations in